Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2010
June 2010, Vol 1, No 2
June 2010, Vol 1, No 2
CER “Cyberinfrastructure” May Boost Cancer Research
Comparative Effectiveness
June 2010, Vol 1, No 2
Researchers from the University of California and the University of California San Diego (UCSD) have begun working on a prototype “cyberinfrastructure” that would allow cancer researchers to collect and interpret data from multiple sources to compare the effectiveness of preventive measures, drugs, treatments, and interventions during the course of clinical trials.
Read Article
Oncology-related Updates from the US Food and Drug Administration
FDA Approvals, News & Updates
June 2010, Vol 1, No 2
Read Article
Cervical Cancer Screening Only Marginally Improved
By
Rosemary Frei, MSc
Genetic Testing
,
In the Literature
,
Personalized Medicine
June 2010, Vol 1, No 2
A new study suggests that removing financial incentives for screening for cervical cancer, diabetic retinopathy, and hypertension and diabetes control reduces performance, including screening rates. The study was published online in May in the
British Medical Journal
(2010;340:c1898).
Read Article
Premarket Policies May Generate the Best Value
By
Jayson Slotnik, JD, MPH
Value-Based Care
,
VBCC Perspectives
June 2010, Vol 1, No 2
The Patient Protection and Affordable Care Act (PPACA), which is Congress’ latest attempt to reform our healthcare system, creates 3 new entities that will test new payment methodologies or compare current treatments in an attempt to determine better value for our healthcare dollar.
Read Article
Keep a Close Eye on Heart and Liver Transplant Patients
2nd European Lung Cancer Conference
June 2010, Vol 1, No 2
Read Article
Accelerated Radiotherapy Brings Survival Benefit
2nd European Lung Cancer Conference
June 2010, Vol 1, No 2
Geneva—Giving lung cancer patients radiotherapy more frequently and over a shorter period of time provides an overall survival benefit, according to the results of a meta-analysis presented at the 2nd European Lung Cancer Conference.
Read Article
Radiation with Pemetrexed a Possibility
2nd European Lung Cancer Conference
June 2010, Vol 1, No 2
Geneva—Combining high-dose pemetrexed (Alimta, Eli Lilly) with concurrent radiation for lung cancer is feasible, according to results of a phase 1 study presented at the 2nd European Lung Cancer Conference. Administering pemetrexed at high doses with radiation may increase the effectiveness of treatment.
Read Article
An Early Look at New Drugs on the Horizon
AMCP Annual Meeting
June 2010, Vol 1, No 2
Washington, DC—A first look at new cancer therapies was the focus of the 6th annual New Drugs on the Horizon symposium held as a special session at the American Association for Cancer Research (AACR) annual meeting.
Read Article
$3 Million to Toss a Life Ring?
AACR Annual Meeting
June 2010, Vol 1, No 2
Washington, DC—Three million dollars to toss a life ring? That’s what the pharmaceutical industry would charge, the director of Medical Ethics at Harvard’s School of Medicine suggested at the 101st Annual Meeting of the American Association for Cancer Research (AACR), held April 17-21 in Washington, DC.
Read Article
Circulating Tumor Cells Signal Worse Survival
IMPAKT Breast Cancer Conference
June 2010, Vol 1, No 2
Brussels—A retrospective study of patients with metastatic breast cancer shows that the number of circulating tumor cells in the patient’s bloodstream prognosticates the length of their survival, information that can be used to adjust treatment at the end of life.
Read Article
Page 1 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma